Redhill Capital: Strategy in a Pandemic
商品編號：W25005
出版日期：2021/11/04
再版日期：2021/11/04
商品來源：Ivey
商品主題：Entrepreneurship; Strategy
商品類型：Case (Field)
涵蓋議題：innovation;China;venture capital;early stage financing;technology financing;private equity;limited partnership;general partner;fund raising;due diligence;funding;cash call;carried interest;biotech;medtech;healthcare;globalization;pandemic;COVID-19
難易度：4 - Undergraduate/MBA
內容長度：16 頁
地域：China
產業：Finance and Insurance;
事件年度：2020
In late May 2020, the two founding and managing partners at Redhill Capital, in the Pearl River New City district of Guangzhou, China, were considering various reasons why the year was developing far differently than they had expected. The two-year-old venture capital firm’s limited partners and investees were all shocked by the dire developments, as was the entire country and the whole world. Earlier that year, rapidly spreading outbreaks of COVID-19, which had started in Wuhan, in China’s Hubei province, had led to hundreds of thousands of deaths, and many countries were closing down their borders. With the world seemingly plunging into a deep depression, the two founders of Redhill Capital were wondering about the future of their venture capital firm, which normally invested in medical technology and biotechnology. How should the company’s strategy be adjusted to survive the crisis and take advantage of new opportunities in the rapidly changing world?
教學手冊：
補充材料：